Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. – MIDAS

Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates.

Abstract

No abstract available.

MIDAS Network Members

Alicia Kraay

PostDoc Fellow
Emory University

Andreas Handel

Associate Professor
University of Georgia

Ben Lopman

Professor
Emory University

Katia Koelle

Principal Investigator
Emory University

Kristin Nelson

PostDoc
Emory University

Molly Gallagher

PostDoc
Emory University

Citation:

Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, Orenstein WA, Lopman B, Handel A, Koelle K. (2020). Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. Nature medicine